24 min

FUMS 033 – MS Challenges and Lyfebulb Moments with Dr. Karin Hehenberger FUMS: Giving Multiple Sclerosis The Finger

    • Alternative Health

Today’s guest on the FUMS Podcast is Dr. Karin Hehenberger. After being diagnosed with type 1 diabetes at a young age, Karin has since gone on to dedicate her life to helping others impacted by chronic disease.

She eventually created Lyfebulb, an innovative patient-empowerment platform whose mission is to reduce the burden of chronic disease through the power of the patient - an idea that all of us in the FUMS nation can get behind!

Most excitingly, Karin talks about the forthcoming MS Innovation Challenge, which looks to support patient entrepreneurs whose companies are developing solutions which address needs currently unmet in MS.

Topics covered include: Karin's life with chronic disease and her decision to go into medicine Lyfeulb's mission and aims The partnership between Lyfebulb and pharmaceutical company Celegen which led to the MS Innovation Challenge- and how YOU could get involved! … and so much more!

Resources mentioned in this episode (clickable links): Lyfebulb website Addressing Unmet Needs in MS: Innovation Challenge application portal(closes April 12 2019) Lyfebulb on Facebook Lyfebulb YouTube channel Lyfebulb on Twitter ** Sign up for the FUMS Friday Night 6 Pack at FUMSnow.com. And for more information about Patients Getting Paid, please visit FUMSnow.com/PatientsGettingPaid.

**If you get value from the FUMSnow Podcast Show, please consider leaving a rating or review wherever you get your podcasts. Reviews are really important and help to spread the word about what we do. It's quick and easy to do and we have some instructions here. Thanks for your time and support!

**Don’t forget to join us on the FUMS Facebook Pageand on Twitter at FUMS. Have an idea for a topic or someone to interview? Perhaps YOU?? Send me an email at Kathy@FUMSnow.com.

And remember to speak to this stupid disease as it deserves: tell it FUMS every day!!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today’s guest on the FUMS Podcast is Dr. Karin Hehenberger. After being diagnosed with type 1 diabetes at a young age, Karin has since gone on to dedicate her life to helping others impacted by chronic disease.

She eventually created Lyfebulb, an innovative patient-empowerment platform whose mission is to reduce the burden of chronic disease through the power of the patient - an idea that all of us in the FUMS nation can get behind!

Most excitingly, Karin talks about the forthcoming MS Innovation Challenge, which looks to support patient entrepreneurs whose companies are developing solutions which address needs currently unmet in MS.

Topics covered include: Karin's life with chronic disease and her decision to go into medicine Lyfeulb's mission and aims The partnership between Lyfebulb and pharmaceutical company Celegen which led to the MS Innovation Challenge- and how YOU could get involved! … and so much more!

Resources mentioned in this episode (clickable links): Lyfebulb website Addressing Unmet Needs in MS: Innovation Challenge application portal(closes April 12 2019) Lyfebulb on Facebook Lyfebulb YouTube channel Lyfebulb on Twitter ** Sign up for the FUMS Friday Night 6 Pack at FUMSnow.com. And for more information about Patients Getting Paid, please visit FUMSnow.com/PatientsGettingPaid.

**If you get value from the FUMSnow Podcast Show, please consider leaving a rating or review wherever you get your podcasts. Reviews are really important and help to spread the word about what we do. It's quick and easy to do and we have some instructions here. Thanks for your time and support!

**Don’t forget to join us on the FUMS Facebook Pageand on Twitter at FUMS. Have an idea for a topic or someone to interview? Perhaps YOU?? Send me an email at Kathy@FUMSnow.com.

And remember to speak to this stupid disease as it deserves: tell it FUMS every day!!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

24 min